CD4 and breast cancer: CXC chemokine ligand 17 (CXCL17), a novel CXC chemokine consisting of 119 amino acids, is negatively correlated with CD4+ T cell aggregation and promotes BC growth and metastasis through significant pro-angiogenic effects.